{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T12:50:16Z","timestamp":1790167816265,"version":"4.1.0"},"reference-count":88,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,11,28]],"date-time":"2024-11-28T00:00:00Z","timestamp":1732752000000},"content-version":"am","delay-in-days":454,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100004488","name":"Croatian Science Foundation","doi-asserted-by":"publisher","award":["UIP-2019-04-5692"],"award-info":[{"award-number":["UIP-2019-04-5692"]}],"id":[{"id":"10.13039\/501100004488","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001677","name":"INSERM","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001677","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004319","name":"Pfizer Global Pharmaceuticals","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100019125","name":"Sorbonne University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100019125","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","lipidjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical Lipidology"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1016\/j.jacl.2023.07.003","type":"journal-article","created":{"date-parts":[[2023,7,27]],"date-time":"2023-07-27T09:26:01Z","timestamp":1690449961000},"page":"643-658","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Integrated omics approach for the identification of HDL structure-function relationships in PCSK9-related familial hypercholesterolemia"],"prefix":"10.1016","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2230-9044","authenticated-orcid":false,"given":"Maryam","family":"Darabi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"Lhomme","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maharajah","family":"Ponnaiah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maja","family":"Pu\u010di\u0107-Bakovi\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6073-0529","authenticated-orcid":false,"given":"Isabelle","family":"Guillas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Frisdal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Randa","family":"Bittar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5449-5817","authenticated-orcid":false,"given":"Mika\u00ebl","family":"Croyal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucr\u00e8ce","family":"Matheron-Duriez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucie","family":"Poupel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4689-9202","authenticated-orcid":false,"given":"Dominique","family":"Bonnefont-Rousselot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corinne","family":"Frere","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathilde","family":"Varret","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michel","family":"Krempf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bertrand","family":"Cariou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gordan","family":"Lauc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0150-1360","authenticated-orcid":false,"given":"Maryse","family":"Guerin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alain","family":"Carrie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Bruckert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1863-1711","authenticated-orcid":false,"given":"Philippe","family":"Giral","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wilfried","family":"Le Goff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9008-7335","authenticated-orcid":false,"given":"Anatol","family":"Kontush","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jacl.2023.07.003_bib0001","doi-asserted-by":"crossref","first-page":"2995","DOI":"10.1172\/JCI29383","article-title":"Secreted PCSK9 decreases the number of LDL receptors in hepatocytes and in livers of parabiotic mice","volume":"116","author":"Lagace","year":"2006","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jacl.2023.07.003_bib0002","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1161\/ATVBAHA.110.204040","article-title":"Increased secretion of lipoproteins in transgenic mice expressing human D374Y PCSK9 under physiological genetic control","volume":"30","author":"Herbert","year":"2010","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jacl.2023.07.003_bib0003","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1038\/nrd4279","article-title":"HDL-targeted therapies: progress, failures and future","volume":"13","author":"Kingwell","year":"2014","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.jacl.2023.07.003_bib0004","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.tibs.2006.12.008","article-title":"Molecular biology of PCSK9: its role in LDL metabolism","volume":"32","author":"Horton","year":"2007","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.jacl.2023.07.003_bib0005","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1007\/s11789-017-0085-0","article-title":"PCSK9 targets important for lipid metabolism","volume":"12","author":"Schulz","year":"2017","journal-title":"Clin Res Cardiol Suppl"},{"key":"10.1016\/j.jacl.2023.07.003_bib0006","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1038\/ng1161","article-title":"Mutations in PCSK9 cause autosomal dominant hypercholesterolemia","volume":"34","author":"Abifadel","year":"2003","journal-title":"Nat Genet"},{"key":"10.1016\/j.jacl.2023.07.003_bib0007","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1093\/hmg\/ddl077","article-title":"Effect of mutations in the PCSK9 gene on the cell surface LDL receptors","volume":"15","author":"Cameron","year":"2006","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.jacl.2023.07.003_bib0008","doi-asserted-by":"crossref","first-page":"28856","DOI":"10.1074\/jbc.M109.037085","article-title":"Dissection of the endogenous cellular pathways of PCSK9-induced low density lipoprotein receptor degradation. Evidence for an intracellular route","volume":"284","author":"Poirier","year":"2009","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jacl.2023.07.003_bib0009","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s10038-003-0114-3","article-title":"Genetic variants in PCSK9 affect the cholesterol level in Japanese","volume":"49","author":"Shioji","year":"2004","journal-title":"J Hum Genet"},{"key":"10.1016\/j.jacl.2023.07.003_bib0010","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/2050-7771-1-27","article-title":"Proprotein convertases in high-density lipoprotein metabolism","volume":"1","author":"Choi","year":"2013","journal-title":"Biomark Res"},{"key":"10.1016\/j.jacl.2023.07.003_bib0011","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.cmet.2007.07.009","article-title":"Hepatic Proprotein Convertases Modulate HDL Metabolism","volume":"6","author":"Jin","year":"2007","journal-title":"Cell Metab"},{"key":"10.1016\/j.jacl.2023.07.003_bib0012","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1161\/CIRCRESAHA.121.319272","article-title":"PCSK9 activity is potentiated through HDL binding","volume":"129","author":"Burnap","year":"2021","journal-title":"Circ Res"},{"key":"10.1016\/j.jacl.2023.07.003_bib0013","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.yjmcc.2021.02.004","article-title":"Lipoprotein compartmentalisation as a regulator of PCSK9 activity","volume":"155","author":"Burnap","year":"2021","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.jacl.2023.07.003_bib0014","doi-asserted-by":"crossref","DOI":"10.1016\/j.jlr.2022.100272","article-title":"PCSK9 is minimally associated with HDL but impairs the anti-atherosclerotic HDL effects on endothelial cell activation","volume":"63","author":"Dafnis","year":"2022","journal-title":"J Lipid Res"},{"key":"10.1016\/j.jacl.2023.07.003_bib0015","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1093\/cvr\/cvu147","article-title":"HDL-mediated mechanisms of protection in cardiovascular disease","volume":"103","author":"Kontush","year":"2014","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.jacl.2023.07.003_bib0016","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/S0140-6736(12)60312-2","article-title":"Plasma HDL cholesterol and risk of myocardial infarction: a mendelian randomisation study","volume":"380","author":"Voight","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.jacl.2023.07.003_bib0017","doi-asserted-by":"crossref","first-page":"2715","DOI":"10.1161\/ATVBAHA.113.301468","article-title":"Small, dense high-density lipoprotein-3 particles are enriched in negatively charged phospholipids: relevance to cellular cholesterol efflux, antioxidative, antithrombotic, anti-inflammatory, and antiapoptotic functionalities","volume":"33","author":"Camont","year":"2013","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jacl.2023.07.003_bib0018","doi-asserted-by":"crossref","DOI":"10.1096\/fj.201800810R","article-title":"Phosphatidylserine enhances anti-inflammatory effects of reconstituted HDL in macrophages via distinct intracellular pathways","volume":"36","author":"Darabi","year":"2022","journal-title":"FASEB J"},{"key":"10.1016\/j.jacl.2023.07.003_bib0019","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1172\/jci.insight.131491","article-title":"Structure-function relationships of HDL in diabetes and coronary heart disease","volume":"5","author":"Cardner","year":"2020","journal-title":"JCI Insight"},{"key":"10.1016\/j.jacl.2023.07.003_bib0020","doi-asserted-by":"crossref","first-page":"2509","DOI":"10.1194\/jlr.M051631","article-title":"Defective functionality of HDL particles in familial apoA-I deficiency: relevance of alterations in HDL lipidome and proteome","volume":"55","author":"Rached","year":"2014","journal-title":"J Lipid Res"},{"key":"10.1016\/j.jacl.2023.07.003_bib0021","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1016\/j.bbalip.2015.05.007","article-title":"Defective functionality of small, dense HDL3 subpopulations in ST segment elevation myocardial infarction: relevance of enrichment in lysophosphatidylcholine, phosphatidic acid and serum amyloid A","volume":"1851","author":"Rached","year":"2015","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.jacl.2023.07.003_bib0022","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1161\/ATVBAHA.111.227181","article-title":"Atheroprotective reverse cholesterol transport pathway is defective in familial hypercholesterolemia","volume":"31","author":"Bellanger","year":"2011","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jacl.2023.07.003_bib0023","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.jacl.2015.10.006","article-title":"Small, dense high-density lipoprotein 3 particles exhibit defective antioxidative and anti-inflammatory function in familial hypercholesterolemia: partial correction by low-density lipoprotein apheresis","volume":"10","author":"Hussein","year":"2016","journal-title":"J Clin Lipidol"},{"key":"10.1016\/j.jacl.2023.07.003_bib0024","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1515\/cclm-2018-1037","article-title":"Lipid profile and genetic status in a familial hypercholesterolemia pediatric population: exploring the LDL\/HDL ratio","volume":"57","author":"Di Taranto","year":"2019","journal-title":"Clin Chem Lab Med"},{"key":"10.1016\/j.jacl.2023.07.003_bib0025","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.atherosclerosis.2012.04.006","article-title":"Identification and characterization of new gain-of-function mutations in the PCSK9 gene responsible for autosomal dominant hypercholesterolemia","volume":"223","author":"Abifadel","year":"2012","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jacl.2023.07.003_bib0026","doi-asserted-by":"crossref","first-page":"2654","DOI":"10.1161\/01.ATV.0000190668.94752.ab","article-title":"Severe Hypercholesterolemia in Four British Families With the D374Y Mutation in the PCSK9 Gene Long-Term Follow-Up and Treatment Response","volume":"25","author":"Naoumova","year":"2005","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jacl.2023.07.003_bib0027","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2022.925587","article-title":"Effects of PCSK9 inhibitors on HDL cholesterol efflux and serum cholesterol loading capacity in familial hypercholesterolemia subjects: a multi-lipid-center real-world evaluation","volume":"9","author":"Palumbo","year":"2022","journal-title":"Front Mol Biosci"},{"key":"10.1016\/j.jacl.2023.07.003_bib0028","doi-asserted-by":"crossref","DOI":"10.1016\/j.vph.2020.106804","article-title":"Treatment with PCSK9 inhibitors induces a more anti-atherogenic HDL lipid profile in patients at high cardiovascular risk","volume":"135","author":"Ingueneau","year":"2020","journal-title":"Vascul Pharmacol"},{"key":"10.1016\/j.jacl.2023.07.003_bib0030","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1111\/cge.13250","article-title":"Single, short in-del, and copy number variations detection in monogenic dyslipidemia using a next-generation sequencing strategy","volume":"94","author":"Marmontel","year":"2018","journal-title":"Clin Genet"},{"key":"10.1016\/j.jacl.2023.07.003_bib0031","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1111\/cge.13832","article-title":"Development of a new expanded next-generation sequencing panel for genetic diseases involved in dyslipidemia","volume":"98","author":"Marmontel","year":"2020","journal-title":"Clin Genet"},{"key":"10.1016\/j.jacl.2023.07.003_bib0032","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1093\/eurjpc\/zwaa451","article-title":"Next-generation sequencing to confirm clinical familial hypercholesterolemia","volume":"28","author":"Reeskamp","year":"2021","journal-title":"Eur J Prev Cardiol"},{"key":"10.1016\/j.jacl.2023.07.003_bib0033","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1002\/humu.21660","article-title":"Genetic variation in APOB, PCSK9, and ANGPTL3 in carriers of pathogenic autosomal dominant hypercholesterolemic mutations with unexpected low LDL-Cl Levels","volume":"33","author":"Huijgen","year":"2012","journal-title":"Hum Mutat"},{"key":"10.1016\/j.jacl.2023.07.003_bib0034","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1194\/jlr.M300250-JLR200","article-title":"Periodontitis decreases the antiatherogenic potency of high density lipoprotein","volume":"45","author":"Pussinen","year":"2004","journal-title":"J Lipid Res"},{"key":"10.1016\/j.jacl.2023.07.003_bib0035","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/S0022-2275(20)35376-1","article-title":"A density gradient ultracentrifugal procedure for the isolation of the major lipoprotein classes from human serum","volume":"22","author":"Chapman","year":"1981","journal-title":"J Lipid Res"},{"key":"10.1016\/j.jacl.2023.07.003_bib0036","doi-asserted-by":"crossref","first-page":"3738","DOI":"10.1210\/jc.2003-030191","article-title":"Action of ciprofibrate in type IIB hyperlipoproteinemia: modulation of the atherogenic lipoprotein phenotype and stimulation of high-density lipoprotein-mediated cellular cholesterol efflux","volume":"88","author":"Guerin","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jacl.2023.07.003_bib0037","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.atherosclerosis.2013.01.046","article-title":"Plasma lipid transfer proteins and cardiovascular disease . The Framingham Heart Study","volume":"228","author":"Robins","year":"2013","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jacl.2023.07.003_bib0038","doi-asserted-by":"crossref","first-page":"2855","DOI":"10.1096\/fj.12-225169","article-title":"Inhibitory effects of in vivo oxidized high-density lipoproteins on platelet aggregation: evidence from patients with abetalipoproteinemia","volume":"27","author":"Calzada","year":"2013","journal-title":"FASEB J"},{"key":"10.1016\/j.jacl.2023.07.003_bib0039","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.atherosclerosis.2007.08.009","article-title":"Metabolic syndrome features small, apolipoprotein A-I-poor, triglyceride-rich HDL3 particles with defective anti-apoptotic activity","volume":"197","author":"De Souza","year":"2008","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jacl.2023.07.003_bib0040","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.atherosclerosis.2005.03.001","article-title":"A normotriglyceridemic, low HDL-cholesterol phenotype is characterised by elevated oxidative stress and HDL particles with attenuated antioxidative activity","volume":"182","author":"Kontush","year":"2005","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jacl.2023.07.003_bib0041","doi-asserted-by":"crossref","first-page":"317","DOI":"10.2165\/11592280-000000000-00000","article-title":"Blood pressure-lowering response to amlodipine as a determinant of the antioxidative activity of small, dense HDL3","volume":"11","author":"Hansel","year":"2011","journal-title":"Am J Cardiovasc Drugs"},{"key":"10.1016\/j.jacl.2023.07.003_bib0042","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1161\/ATVBAHA.112.300979","article-title":"Genetic determination of plasma cholesterol efflux capacity is gender-specific and independent of HDL-cholesterol levels","volume":"33","author":"Villard","year":"2013","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jacl.2023.07.003_bib0043","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1016\/S0022-2275(20)31582-0","article-title":"A cell-free assay for detecting HDL that is dysfunctional in preventing the formation of or inactivating oxidized phospholipids","volume":"42","author":"Navab","year":"2001","journal-title":"J Lipid Res"},{"key":"10.1016\/j.jacl.2023.07.003_bib0044","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/ijms22020719","article-title":"Endothelial lipase modulates paraoxonase 1 content and arylesterase activity of HDL","volume":"22","author":"Schilcher","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jacl.2023.07.003_bib0045","doi-asserted-by":"crossref","first-page":"5239","DOI":"10.1021\/pr100520x","article-title":"Proteomic characterization of human plasma high density lipoprotein fractionated by gel filtration chromatography","volume":"9","author":"Gordon","year":"2010","journal-title":"J Proteome Res"},{"key":"10.1016\/j.jacl.2023.07.003_bib0046","first-page":"934","article-title":"High-throughput glycomics: optimization of sample preparation","volume":"80","author":"Ugrina","year":"2015","journal-title":"Biochem"},{"key":"10.1016\/j.jacl.2023.07.003_bib0047","first-page":"643","article-title":"Glycosylation of human plasma lipoproteins reveals a high level of diversity, which directly impacts their functional properties","volume":"1864","author":"Pu\u010di\u0107-Bakovi\u0107","year":"2019","journal-title":"Biochim Biophys Acta - Mol Cell Biol Lipids"},{"key":"10.1016\/j.jacl.2023.07.003_bib0048","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1002\/1615-9861(200102)1:2<340::AID-PROT340>3.0.CO;2-B","article-title":"GlycoMod - A software tool for determining glycosylation compositions from mass spectrometric data","volume":"1","author":"Cooper","year":"2001","journal-title":"Proteomics"},{"key":"10.1016\/j.jacl.2023.07.003_bib0049","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1021\/pr7008252","article-title":"GlycoWorkbench: a tool for the computer-assisted annotation of mass spectra of glycans","volume":"7","author":"Dell","year":"2008","journal-title":"J Proteome Res"},{"key":"10.1016\/j.jacl.2023.07.003_bib0050","first-page":"426","article-title":"Cytoscape: a software environment for integrated models","volume":"13","author":"Paul","year":"1971","journal-title":"Genome Res"},{"key":"10.1016\/j.jacl.2023.07.003_bib0051","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1093\/bioinformatics\/btq048","article-title":"Metscape: a Cytoscape plug-in for visualizing and interpreting metabolomic data in the context of human metabolic networks","volume":"26","author":"Gao","year":"2010","journal-title":"Bioinformatics"},{"key":"10.1016\/j.jacl.2023.07.003_bib0052","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","article-title":"Controlling the false discovery rate: a practical and powerful approach to multiple testing","volume":"57","author":"Benjamini","year":"1995","journal-title":"J R Stat Soc Ser B"},{"key":"10.1016\/j.jacl.2023.07.003_bib0053","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0021-9150(88)90184-0","article-title":"Removal of apolipoprotein E-enriched high density lipoprotein by LDL-apheresis in familial hypercholesterolaemia: a possible activation of the reverse cholesterol transport system","volume":"74","author":"Koizumi","year":"1988","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jacl.2023.07.003_bib0054","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1160\/TH13-07-0612","article-title":"Circulating CD45+\/CD3+ lymphocyte-derived microparticles map lipid-rich atherosclerotic plaques in familial hypercholesterolaemia patients","volume":"111","author":"Suades","year":"2013","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jacl.2023.07.003_bib0055","doi-asserted-by":"crossref","first-page":"4963","DOI":"10.1210\/jc.2004-0305","article-title":"Metabolic syndrome is associated with elevated oxidative stress and dysfunctional dense high-density lipoprotein particles displaying impaired antioxidative activity","volume":"89","author":"Hansel","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jacl.2023.07.003_bib0056","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1194\/jlr.M600309-JLR200","article-title":"Inability of HDL from abdominally obese subjects to counteract the inhibitory effect of oxidized LDL on vasorelaxation","volume":"48","author":"Pers\u00e9gol","year":"2007","journal-title":"J Lipid Res"},{"key":"10.1016\/j.jacl.2023.07.003_bib0057","first-page":"1","article-title":"Dysfunctional high-density lipoproteins have distinct composition, diminished anti- inflammatory potential and discriminate acute coronary syndrome from stable coronary artery disease patients","author":"Carnuta","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.jacl.2023.07.003_bib0058","first-page":"704","article-title":"[Effects of plasma very low density lipoprotein, low density lipoprotein and high density lipoprotein on platelet aggregation in endogenous hypertriglyceridemia]","volume":"34","author":"Deng","year":"2003","journal-title":"Sichuan Da Xue Xue Bao Yi Xue Ban"},{"key":"10.1016\/j.jacl.2023.07.003_bib0059","doi-asserted-by":"crossref","first-page":"2548","DOI":"10.1161\/CIRCULATIONAHA.104.475715","article-title":"Macrophage reverse cholesterol transport: key to the regression of atherosclerosis?","volume":"113","author":"Cuchel","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.jacl.2023.07.003_bib0060","doi-asserted-by":"crossref","first-page":"S189","DOI":"10.1194\/jlr.R800088-JLR200","article-title":"The role of reverse cholesterol transport in animals and humans and relationship to atherosclerosis","volume":"50 Suppl","author":"Rader","year":"2009","journal-title":"J Lipid Res"},{"key":"10.1016\/j.jacl.2023.07.003_bib0061","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1056\/NEJMoa1001689","article-title":"Cholesterol efflux capacity, high-density lipoprotein function, and atherosclerosis","volume":"364","author":"Khera","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacl.2023.07.003_bib0062","doi-asserted-by":"crossref","first-page":"2383","DOI":"10.1056\/NEJMoa1409065","article-title":"HDL cholesterol efflux capacity and incident cardiovascular events","volume":"371","author":"Rohatgi","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacl.2023.07.003_bib0063","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1186\/1476-511X-12-112","article-title":"Decreased APOE-containing HDL subfractions and cholesterol efflux capacity of serum in mice lacking Pcsk9","volume":"12","author":"Choi","year":"2013","journal-title":"Lipids Health Dis"},{"key":"10.1016\/j.jacl.2023.07.003_bib0064","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.ab.2013.06.018","article-title":"A fluorescence method to detect and quantitate sterol esterification by lecithin:cholesterol acyltransferase","volume":"441","author":"Homan","year":"2013","journal-title":"Anal Biochem"},{"key":"10.1016\/j.jacl.2023.07.003_bib0065","doi-asserted-by":"crossref","first-page":"2678","DOI":"10.1210\/jc.2003-031965","article-title":"Serum haptoglobin: a novel marker of adiposity in humans","volume":"89","author":"Chiellini","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jacl.2023.07.003_bib0066","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1007\/BF03346317","article-title":"Haptoglobin serum levels are independently associated with insulinemia in overweight and obese women","volume":"30","author":"De Pergola","year":"2007","journal-title":"J Endocrinol Invest"},{"key":"10.1016\/j.jacl.2023.07.003_bib0067","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1161\/01.RES.0000251741.65179.56","article-title":"Haptoglobin genotype is a regulator of reverse cholesterol transport in diabetes in vitro and in vivo","volume":"99","author":"Asleh","year":"2006","journal-title":"Circ Res"},{"key":"10.1016\/j.jacl.2023.07.003_bib0068","first-page":"999","article-title":"Retinol-binding protein 4 and its potential roles in hypercholesterolemia revealed by proteomics","volume":"14","author":"Jugnam-Ang","year":"2015","journal-title":"Excli J"},{"key":"10.1016\/j.jacl.2023.07.003_bib0069","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1194\/jlr.R035964","article-title":"HDL and cholesterol: life after the divorce? 1","volume":"55","author":"Vickers","year":"2014","journal-title":"J Lipid Res"},{"key":"10.1016\/j.jacl.2023.07.003_bib0070","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.atherosclerosis.2018.04.003","article-title":"Remodeling of the HDL proteome with treatment response to abatacept or adalimumab in the AMPLE trial of patients with rheumatoid arthritis","volume":"275","author":"Charles-Schoeman","year":"2018","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jacl.2023.07.003_bib0071","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1172\/JCI26206","article-title":"Shotgun proteomics implicates protease inhibition and complement activation in the antiinflammatory properties of HDL","volume":"117","author":"Vaisar","year":"2007","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jacl.2023.07.003_bib0072","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1097\/00041433-200310000-00008","article-title":"Role of complement activation in atherosclerosis","volume":"14","author":"Oksjoki","year":"2003","journal-title":"Curr Opin Lipidol"},{"key":"10.1016\/j.jacl.2023.07.003_bib0073","doi-asserted-by":"crossref","first-page":"5109","DOI":"10.1021\/acs.jproteome.5b00730","article-title":"Combined high-density lipoprotein proteomic and glycomic profiles in patients at risk for coronary artery disease","volume":"14","author":"Zivkovic","year":"2015","journal-title":"J Proteome Res"},{"key":"10.1016\/j.jacl.2023.07.003_bib0074","article-title":"Impact of protein glycosylation on lipoprotein metabolism and atherosclerosis","author":"Pirillo","year":"2020","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.jacl.2023.07.003_bib0075","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0104833","article-title":"Reduced apolipoprotein glycosylation in patients with the metabolic syndrome","volume":"9","author":"Savinova","year":"2014","journal-title":"PLoS ONE"},{"key":"10.1016\/j.jacl.2023.07.003_bib0076","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/j.bbalip.2019.01.005","article-title":"Glycosylation of human plasma lipoproteins reveals a high level of diversity, which directly impacts their functional properties","volume":"1864","author":"Sukhorukov","year":"2019","journal-title":"Biochim Biophys Acta - Mol Cell Biol Lipids"},{"key":"10.1016\/j.jacl.2023.07.003_bib0077","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.atherosclerosis.2012.06.010","article-title":"Targeted profiling of atherogenic phospholipids in human plasma and lipoproteins of hyperlipidemic patients using MALDI-QIT-TOF-MS\/MS","volume":"224","author":"St\u00fcbiger","year":"2012","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jacl.2023.07.003_bib0078","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/ijms20051149","article-title":"An updated review of lysophosphatidylcholine metabolism in human diseases","volume":"20","author":"Law","year":"2019","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jacl.2023.07.003_bib0079","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1016\/j.yjmcc.2003.08.004","article-title":"Lysophosphatidylcholine regulates human microvascular endothelial cell expression of chemokines","volume":"35","author":"Murugesan","year":"2003","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.jacl.2023.07.003_bib0080","doi-asserted-by":"crossref","first-page":"11033","DOI":"10.1074\/jbc.RA118.002752","article-title":"Lysophospholipids induce innate immune transdifferentiation of endothelial cells, resulting in prolonged endothelial activation","volume":"293","author":"Li","year":"2018","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jacl.2023.07.003_bib0081","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.numecd.2018.01.012","article-title":"Lipoprotein-associated phospholipase A\u2082 activity is increased in patients with definite familial hypercholesterolemia compared with other forms of hypercholesterolemia","volume":"28","author":"Mattina","year":"2018","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"10.1016\/j.jacl.2023.07.003_bib0082","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.pharmthera.2015.10.010","article-title":"Therapeutic applications of reconstituted HDL: when structure meets function","volume":"157","author":"Darabi","year":"2015","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.jacl.2023.07.003_bib0083","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.atherosclerosis.2018.01.004","article-title":"PCSK9 inhibition alters the lipidome of plasma and lipoprotein fractions","volume":"269","author":"Hilvo","year":"2018","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jacl.2023.07.003_bib0084","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1161\/ATVBAHA.107.145672","article-title":"Preferential sphingosine-1-phosphate enrichment and sphingomyelin depletion are key features of small dense HDL3 particles: relevance to antiapoptotic and antioxidative activities","volume":"27","author":"Kontush","year":"2007","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jacl.2023.07.003_bib0085","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.tem.2017.03.005","article-title":"Sphingolipids and lipoproteins in health and metabolic disorders","volume":"28","author":"Iqbal","year":"2017","journal-title":"Trends Endocrinol Metab"},{"key":"10.1016\/j.jacl.2023.07.003_bib0086","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0126910","article-title":"Ceramide as a mediator of non-alcoholic fatty liver disease and associated atherosclerosis","volume":"10","author":"Kasumov","year":"2015","journal-title":"PLoS ONE"},{"key":"10.1016\/j.jacl.2023.07.003_bib0087","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/j.atherosclerosis.2008.07.047","article-title":"Acute hypertriglyceridaemia in humans increases the triglyceride content and decreases the anti-inflammatory capacity of high density lipoproteins","volume":"204","author":"Patel","year":"2009","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jacl.2023.07.003_bib0088","doi-asserted-by":"crossref","first-page":"34480","DOI":"10.1074\/jbc.M103782200","article-title":"Suppression of Endothelial Cell Apoptosis by High Density Lipoproteins (HDL) and HDL-associated Lysosphingolipids *","volume":"276","author":"Nofer","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jacl.2023.07.003_bib0089","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1111\/j.1582-4934.2009.00713.x","article-title":"Small, dense HDL 3 particles attenuate apoptosis in endothelial cells: pivotal role of apolipoprotein A-I","volume":"14","author":"de Souza","year":"2010","journal-title":"J Cell Mol Med"}],"container-title":["Journal of Clinical Lipidology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1933287423002271?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1933287423002271?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T08:17:35Z","timestamp":1778833055000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1933287423002271"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":88,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023,9]]}},"alternative-id":["S1933287423002271"],"URL":"https:\/\/doi.org\/10.1016\/j.jacl.2023.07.003","relation":{},"ISSN":["1933-2874"],"issn-type":[{"value":"1933-2874","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Integrated omics approach for the identification of HDL structure-function relationships in PCSK9-related familial hypercholesterolemia","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical Lipidology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacl.2023.07.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 National Lipid Association. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}